D.E. Shaw & Co’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-243,976
| Closed | -$3.69M | – | 4147 |
|
|
2022
Q3 | $3.69M | Sell |
243,976
-4,423
| -2% | -$66.9K | ﹤0.01% | 1702 |
|
|
2022
Q2 | $1.86M | Buy |
248,399
+187,899
| +311% | +$1.41M | ﹤0.01% | 2309 |
|
|
2022
Q1 | $551K | Buy |
+60,500
| New | +$551K | ﹤0.01% | 3163 |
|
|
2021
Q3 | – | Sell |
-21,456
| Closed | -$344K | – | 4090 |
|
|
2021
Q2 | $344K | Buy |
+21,456
| New | +$344K | ﹤0.01% | 3033 |
|
|
2020
Q1 | – | Sell |
-9,438
| Closed | -$228K | – | 2939 |
|
|
2019
Q4 | $228K | Sell |
9,438
-137,331
| -94% | -$3.32M | ﹤0.01% | 2466 |
|
|
2019
Q3 | $2.82M | Buy |
+146,769
| New | +$2.82M | ﹤0.01% | 1424 |
|
|
2017
Q2 | – | Sell |
-5,508
| Closed | -$250K | – | 2621 |
|
|
2017
Q1 | $250K | Buy |
+5,508
| New | +$250K | ﹤0.01% | 2223 |
|
|
2016
Q4 | – | Sell |
-121,896
| Closed | -$4.6M | – | 2700 |
|
|
2016
Q3 | $4.6M | Buy |
121,896
+22,445
| +23% | +$847K | 0.01% | 993 |
|
|
2016
Q2 | $1.75M | Buy |
+99,451
| New | +$1.75M | ﹤0.01% | 1510 |
|
|
2016
Q1 | – | Sell |
-26,833
| Closed | -$653K | – | 2777 |
|
|
2015
Q4 | $653K | Sell |
26,833
-19,356
| -42% | -$471K | ﹤0.01% | 1952 |
|
|
2015
Q3 | $819K | Buy |
46,189
+23,389
| +103% | +$415K | ﹤0.01% | 1820 |
|
|
2015
Q2 | $402K | Buy |
+22,800
| New | +$402K | ﹤0.01% | 2231 |
|